DOHENY ASSET MANAGEMENT /CA - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
DOHENY ASSET MANAGEMENT /CA ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$441,000
-88.0%
47,030
-78.2%
0.32%
-83.2%
Q3 2018$3,669,000
-23.7%
215,445
-23.9%
1.92%
-26.3%
Q2 2018$4,807,000
+56.4%
282,945
+23.6%
2.61%
+61.6%
Q1 2018$3,073,000228,9901.61%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders